ATE553196T1 - Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod - Google Patents

Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod

Info

Publication number
ATE553196T1
ATE553196T1 AT08710243T AT08710243T ATE553196T1 AT E553196 T1 ATE553196 T1 AT E553196T1 AT 08710243 T AT08710243 T AT 08710243T AT 08710243 T AT08710243 T AT 08710243T AT E553196 T1 ATE553196 T1 AT E553196T1
Authority
AT
Austria
Prior art keywords
composition
cell proliferation
modulating
cell death
cell
Prior art date
Application number
AT08710243T
Other languages
English (en)
Inventor
Moshe Oren
Nina Raver-Shapira
Yeal Spector
Efi Marciano
Original Assignee
Rosetta Genomics Ltd
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39608185&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE553196(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rosetta Genomics Ltd, Yeda Res & Dev filed Critical Rosetta Genomics Ltd
Application granted granted Critical
Publication of ATE553196T1 publication Critical patent/ATE553196T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/10—Production naturally occurring

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT08710243T 2007-02-27 2008-02-26 Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod ATE553196T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90352607P 2007-02-27 2007-02-27
PCT/IL2008/000243 WO2008104974A2 (en) 2007-02-27 2008-02-26 Composition and methods for modulating cell proliferation and cell death

Publications (1)

Publication Number Publication Date
ATE553196T1 true ATE553196T1 (de) 2012-04-15

Family

ID=39608185

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08710243T ATE553196T1 (de) 2007-02-27 2008-02-26 Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod

Country Status (6)

Country Link
US (1) US8765702B2 (de)
EP (1) EP2126078B2 (de)
AT (1) ATE553196T1 (de)
AU (1) AU2008220438A1 (de)
CA (1) CA2699418A1 (de)
WO (1) WO2008104974A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007016548A2 (en) * 2005-08-01 2007-02-08 The Ohio State University Research Foundation Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
US8481505B2 (en) * 2005-09-12 2013-07-09 The Ohio State University Research Foundation Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
WO2007081680A2 (en) * 2006-01-05 2007-07-19 The Ohio State University Research Foundation Microrna expression abnormalities in pancreatic endocrine and acinar tumors
EP2484782B1 (de) 2006-01-05 2015-11-18 The Ohio State University Research Foundation Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von soliden Krebs
ES2446362T3 (es) 2006-03-20 2014-03-07 The Ohio State University Research Foundation Huellas de microARN durante megacariocipoyesis humana
ES2425387T3 (es) 2006-07-13 2013-10-15 The Ohio State University Research Foundation Mir-106a para diagnosticar adenocarcinoma de colon de pronóstico de supervivencia pobre
JP2010516291A (ja) 2007-01-31 2010-05-20 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 急性骨髄性白血病(aml)の診断、予後及び治療のためのマイクロrnaに基づく方法及び組成物
US9006206B2 (en) * 2007-02-27 2015-04-14 Rosetta Genomics Ltd. Composition and methods for modulating cell proliferation and cell death
US8399248B2 (en) 2007-05-03 2013-03-19 Merck Sharp & Dohme Corp. Methods of using MIR34 as a biomarker for TP53 functional status
US8053186B2 (en) 2007-06-15 2011-11-08 The Ohio State University Research Foundation Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
EP2173911B1 (de) * 2007-07-31 2014-06-18 The Ohio State University Research Foundation Verfahren zur methylierungsreversion mittels abzielen auf dnmt3a und dnmt3b
EP2653561B1 (de) 2007-08-03 2016-03-02 The Ohio State University Research Foundation Ultrakonservierte Bereiche zur Codierung von ncRNA
EP3028708A1 (de) * 2007-08-22 2016-06-08 The Ohio State University Research Foundation Verfahren und zusammensetzungen zur induzierung von epha7-deregulierung und erk-phosphorlylierung bei humaner akuter leukämie
EP3138926A3 (de) * 2007-09-06 2017-04-05 The Ohio State University Research Foundation Mirna-signaturen in menschlichem ovarialkarzinom
EP2212440A4 (de) * 2007-10-11 2011-04-06 Univ Ohio State Res Found Verfahren und zusammensetzungen zur diagnose und behandlung von adenokarzinomen der speiseröhre
WO2009055773A2 (en) 2007-10-26 2009-04-30 The Ohio State University Research Foundation Methods for identifying fragile histidine triad (fhit) interaction and uses thereof
EP2225396A4 (de) * 2007-11-30 2011-03-02 Univ Ohio State Res Found Mikro-rna-expressionsprofilerstellung und abzielen darauf in peripherem blut bei lungenkrebs
JP5662166B2 (ja) * 2008-02-28 2015-01-28 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイションThe Ohio State University Research Foundation 胃癌の診断、予後診断及び治療のためのマイクロrnaに基づいた方法及び組成物
CA2734179A1 (en) * 2008-08-12 2010-02-18 The Ohio State University Research Foundation Micro-rna-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma
EP2504452A4 (de) 2009-11-23 2014-06-11 Univ Ohio State Res Found Materialien und verfahren zur beeinflussung des wachstums, der migration und der invasion von tumorzellen
US8846631B2 (en) 2010-01-14 2014-09-30 Regulus Therapeutics Inc. MicroRNA compositions and methods
US20130150430A1 (en) * 2010-08-04 2013-06-13 The Ohio State University Methods for Impairing the P53/HDM2 Auto-Regulatory Loop in Multiple Myeloma Development Using mIR-192, mIR-194 and mIR-215
WO2012065049A1 (en) 2010-11-12 2012-05-18 The Ohio State University Research Foundation Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
CA2817982C (en) 2010-11-15 2020-06-30 The Regents Of The University Of Michigan Controlled release mucoadhesive systems
JP2014509852A (ja) 2011-03-07 2014-04-24 ジ・オハイオ・ステート・ユニバーシティ マイクロRNA−155(miR−155)により誘導される変異誘発活性は炎症および癌を結び付ける
CA2852066A1 (en) 2011-10-14 2013-04-18 The Ohio State University Methods and materials related to ovarian cancer
EP2790735A4 (de) 2011-12-13 2015-12-09 Ohio State Innovation Foundation Verfahren und zusammensetzungen im zusammenhang mit mir-21 und mir-29a, exosomerhemmung und krebsmetastasen
JP2015511121A (ja) 2012-01-20 2015-04-16 ジ・オハイオ・ステート・ユニバーシティ 浸潤性および予後に関する乳がんバイオマーカーシグネチャー
US20160145628A1 (en) 2013-06-18 2016-05-26 Ramot At Tel-Aviv University Ltd. Nanocarrier system for micrornas and uses thereof
US10722599B2 (en) 2015-02-04 2020-07-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Lipid assemblies and uses thereof and some pH and electrostatic modulating lipids to be used in said assemblies
US11584932B2 (en) 2016-11-01 2023-02-21 The Research Foundation For The State University Of New York 5-halouracil-modified microRNAs and their use in the treatment of cancer
CN113041255B (zh) * 2021-04-13 2022-10-11 上海中医药大学 一种新发现miRNA–mRNA调控轴介导肺腺癌NCI-H1299细胞焦亡的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
CA2135646A1 (en) 1992-05-11 1993-11-25 Kenneth G. Draper Method and reagent for inhibiting viral replication
JPH07509133A (ja) 1992-07-17 1995-10-12 リボザイム・ファーマシューティカルズ・インコーポレイテッド 動物疾患の処置のための方法および剤
US6395713B1 (en) 1997-07-23 2002-05-28 Ribozyme Pharmaceuticals, Inc. Compositions for the delivery of negatively charged molecules
AU8525098A (en) 1997-07-24 1999-02-16 Inex Pharmaceuticals Corporation Liposomal compositions for the delivery of nucleic acid catalysts
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
EP2669377A3 (de) 2003-04-17 2015-10-14 Alnylam Pharmaceuticals Inc. Modifizierte iRNA-Wirkstoffe
WO2005013901A2 (en) * 2003-07-31 2005-02-17 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for use in modulation of small non-coding rnas
EP1713938A2 (de) 2004-02-09 2006-10-25 Thomas Jefferson University Diagnose und behandlung von krebserkrankungen mit oder nahe mit krebs in zusammenhang stehenden chromosomalen merkmalen lokalisierter microrna
US20050182005A1 (en) 2004-02-13 2005-08-18 Tuschl Thomas H. Anti-microRNA oligonucleotide molecules
EP2471924A1 (de) * 2004-05-28 2012-07-04 Asuragen, INC. Verfahren und Zusammensetzungen mit microRNA
ES2534300T3 (es) 2004-11-12 2015-04-21 Asuragen, Inc. Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
WO2007016548A2 (en) 2005-08-01 2007-02-08 The Ohio State University Research Foundation Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
JP2010516249A (ja) 2007-01-17 2010-05-20 ザ・ジョンズ・ホプキンス・ユニバーシティ 腫瘍治療のためのミクロrnaに関する組成物及び方法

Also Published As

Publication number Publication date
EP2126078B2 (de) 2023-01-04
US20100104662A1 (en) 2010-04-29
WO2008104974A2 (en) 2008-09-04
US8765702B2 (en) 2014-07-01
CA2699418A1 (en) 2008-09-04
AU2008220438A1 (en) 2008-09-04
EP2126078A2 (de) 2009-12-02
WO2008104974A3 (en) 2009-03-05
EP2126078B1 (de) 2012-04-11

Similar Documents

Publication Publication Date Title
WO2008104974A3 (en) Composition and methods for modulating cell proliferation and cell death
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
BR112013007862A2 (pt) ácidos nucleicos manipulados e métodos de uso dos mesmos.
GEP20217251B (en) Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
ATE553195T1 (de) Zusammensetzungen und verfahren mit rna- interferenz opr3-ähnlichem gen zur kontrolle von nematoden
EP4010004A4 (de) Zusammensetzungen und verfahren zur modulation von genexpression
EP4031577A4 (de) Verfahren zur züchtung von natürlichen killerzellen gegen bcma-positive tumoren
EP2061482A4 (de) Verfahren zur modulation der expression von epidermalem wachstumsfaktor-rezeptor (egfr) mit mirna
EP4048792A4 (de) Zusammensetzungen und verfahren zur editierung des cdkl5-gens
EP2603781A4 (de) System und verfahren zur quantifizierung der farbe und intensität von lichtquellen
EP3980068A4 (de) Zellkulturverfahren und zusammensetzungen zur produktion von antikörpern
EA201101478A1 (ru) Композиции и способы модулирования связывания ретинола с ретинолсвязывающим белком 4 (rbp4)
ATE480615T1 (de) Verfahren zur proliferation von stammzellen
EA200970407A1 (ru) Ингибиторы киназ mapk/erk
EP4415728A4 (de) Zusammensetzungen und verfahren zur herstellung von t-zellen
EP2266633A4 (de) Gasdekompositionsvorrichtung und verfahren zur dekomposition von gas
EP3511410A4 (de) Medium zur kultivierung von stammzellen, verfahren zur kultivierung von stammzellen, stammzellenwachstumsförderer und zusammensetzung und verfahren zur herstellung davon
EP4103691C0 (de) Zellkultursubstrate, verfahren und verwendungen davon
EP2133158A4 (de) Verfahren zur entgiftung von asbest
EP4326878A4 (de) Zusammensetzungen und verfahren zur modulierung von sos-genexpressionen
EP4073250A4 (de) Zusammensetzungen und verfahren zur amplifikation von nukleinsäuren
DE102005053064A1 (de) Verfahren zur Herstellung von Pfropfpolymerisaten
ATE540755T1 (de) Verwendung von katalysatorzusammensetzungen und verfahren zur oxychlorierung
EP2118305A4 (de) Verfahren und kits zur dna-amplifikation